Abstract: External preparations for treatment of painful skin wound having an analgesic activity which comprises acetylsalicylic acid or its pharmacologically acceptable salt as an active ingredient.

Abstract: An external preparation containing acetylsalicylic acid or its pharmaceutically acceptable salt as an active ingredient for treating anal diseases having therapeutic activity on hemorrhoids (internal hemorrhoid, external hemorrhoid), hemorrhoidal disease owing to anal fissure and other anal diseases together with activity on pain and pruritus.

Abstract: An external preparation that effectively produces the anti-inflammatory analgesic effect of a non-steroidal anti-inflammatory analgesic agent, and reduces skin irritation on the application site of the preparation and has an excellent effect on pain associated with inflammation such as chronic rheumatoid arthritis, osteoarthritis, and also lumbago is provided. The external preparation includes a non-steroidal anti-inflammatory analgesic agent and oxybuprocaine or a pharmaceutically acceptable salt thereof. The external preparation includes the non-steroidal anti-inflammatory analgesic agent at a content of 0.1 to 10 wt % based on the total weight of the formulation and oxybuprocaine or a pharmaceutically acceptable salt thereof at a content of 0.01 to 60 wt % based on the total weight of the formulation.

Abstract: An analgesic/antipruritic external preparation that includes a local anesthetic, has fewer side effects, and has an excellent therapeutic effect on pain and itching of the skin is provided. The analgesic/antipruritic external preparation includes oxybuprocaine or a pharmaceutically acceptable salt thereof as an active ingredient, and the oxybuprocaine or a pharmaceutically acceptable salt thereof is contained in an amount of 0.1 to 60 wt %, more preferably 1 to 40 wt %, and most preferably 5 to 30 wt %. The analgesic/antipruritic external preparation has a dosage form as an external preparation wherein the dosage form is an ointment, a solution, a suspension, an emulsion, a lotion, a cataplasm, a tape, an aerosol, or a powder for external use.

Abstract: A wiper unit controller for performing wiping at an accurate intermittent wipe cycle. The controller stores a maximum resistance value of a variable resistor having a resistance value that varies in accordance with the intermittent wipe cycle. When a reference time elapses after calculating a resistance value that exceeds the stored maximum resistance value, a computer renews the maximum resistance value with a new maximum resistance value.

Abstract: A controller for controlling a wiper unit including a wiper and an intermittent wipe cycle setting device for setting an intermittent wipe cycle of the wiper. The cycle setting device is set at a plurality of positions respectively corresponding to different intermittent wipe cycles. Further, the cycle setting device has a resistance value, which changes in accordance with each of the positions, and generates an output signal, which is in accordance with the change in the resistance value. The controller computes position information of the intermittent wipe cycle setting device from the output signal by using a learned value. The computer adjusts the learned value in accordance with the computation result of the position information to correct the position information. Accordingly, resistance value variances of the intermittent wipe cycle setting device are automatically corrected.

Abstract: An external preparation containing acetylsalicylic acid or a pharmacologically acceptable salt thereof as an active ingredient, which is used for treatment of vesicle, sore or ulcer of skin or mucosa caused by a viral infection.

Abstract: A wiper unit controller for performing wiping at an accurate intermittent wipe cycle. The controller stores a maximum resistance value of a variable resistor having a resistance value that varies in accordance with the intermittent wipe cycle. When a reference time elapses after calculating a resistance value that exceeds the stored maximum resistance value, a computer renews the maximum resistance value with a new maximum resistance value.

Abstract: A controller for controlling a wiper unit including a wiper and an intermittent wipe cycle setting device for setting an intermittent wipe cycle of the wiper. The cycle setting device is set at a plurality of positions respectively corresponding to different intermittent wipe cycles. Further, the cycle setting device has a resistance value, which changes in accordance with each of the positions, and generates an output signal, which is in accordance with the change in the resistance value. The controller computes position information of the intermittent wipe cycle setting device from the output signal by using a learned value. The computer adjusts the learned value in accordance with the computation result of the position information to correct the position information. Accordingly, resistance value variances of the intermittent wipe cycle setting device are automatically corrected.

Abstract: A neo-vascularization promoter containing acetylsalicylic acid or its pharmaceutically acceptable salt as an active ingredient.

Abstract: An external preparation containing acetylsalicylic acid or its pharmaceutically acceptable salt as an active ingredient for treating anal diseases having therapeutic activity on hemorrhoids (internal hemorrhoid, external hemorrhoid), hemorrhoidal disease owing to anal fissure and other anal diseases together with activity on pain and pruritus.

Abstract: A substantially anhydrous stable ointment containing Aspirin which is characterized in using gelation hydrocarbon and/or vaseline as a base. The ointment is superior in stability and can be stored for a long term.

Abstract: An external preparation which contains acetylsalicylic acid or its salt as an active ingredient and has an effect of inhibiting keloid and/or hypertrophic scar formation as well as an analgesic and antipruritic effect.

Abstract: An ulcerative colitis treating therapeutic agent which is very effective in repairing damaged tissues of ulcerative colitis and yet has no need of fear of side effects as those of steroids is provided. It is an therapeutic agent for treating ulcerative colitis which has peony root, especially, dry powders of peony root, or a Chinese medicine formulation containing peony root as an active ingredient. It is also an therapeutic agent for treating ulcerative colitis which has, as an active ingredient, an infused dry extract of peony root, an infused dry extract of a Chinese medicine formulation containing peony root, or especially an infused dry extract of Jia-Wei-Xiao-Yao-San, Dang-Gui-Shao-Yao-San, Shao-Yao-Gan-Cao-Tang, or Gui-Zhi-Fu-Ling-Wan.

Abstract: An ulcerative colitis treating therapeutic agent which is very effective in repairing damaged tissues of ulcerative colitis and yet has no need of fear of side effects as those of steroids is provided. It is an therapeutic agent for treating ulcerative colitis which has peony root, especially, dry powders of peony root, or a Chinese medicine formulation containing peony root as an active ingredient. It is also an therapeutic agent for treating ulcerative colitis which has, as an active ingredient, an infused dry extract of peony root, an infused dry extract of a Chinese medicine formulation containing peony root, or especially an infused dry extract of Jia-Wei-Xiao-Yao-San, Dang-Gui-Shao-Yao-San, Shao-Yao-Gan-Cao-Tang, or Gui-Zhi-Fu-Ling-Wan.

Abstract: External preparations containing Aspirin which are stored for a long term and superior in dermal absorbability. The preparations are prepared by mixing Aspirin together with at least one substance selected from an ester of an organic acid ester having 2 to 20 carbon atoms, a glycerol fatty acid ester, silicon oil, hydrocarbon oil and crotamiton.

Abstract: A drug for the treatment of skin injuries, particularly hardly curable diseases such as bedsore, which comprises as an active ingredient acetylsalicylic acid. The drug is used in the form of a topical preparation for external application or is administered orally to the patients.